Histologic comparison of the uterine pathologic effects of erythropoietin and U-74389G

Constantinos Tsompos(1*), Constantinos Panoulis(2), Constantinos Zografos(3), GeorgeC Zografos(4), Apostolos Papalois(5)


(1) 1Department of Gynecology, General Hospital of Athens “G. Gennimatas”, 154 Mesogeion avenue, 11527 Athens, Hellas
(2) 22nd Department of Obstetrics & Gynecology, Aretaieio Hospital, University of Athens School of Medicine, 76 Vas. Sofias avenue, 11528 Athens, Hellas
(3) 3Department of Surgery, General Hospital of Laiko, University of Athens School of Medicine, 17 Saint Thomas street, 11527 Athens, Hellas
(4) 41st Department of Surgery, General Hospital of Ippokrateio, University of Athens School of Medicine, 114 Vas. Sofias avenue, 11527 Athens, Hellas
(5) 5a2nd Department of Surgery, Aretaieio Hospital, University of Athens School of Medicine, 76 Vas. Sofias avenue, 11528 Athens, Hellas 5bEuropean University Cyprus, School of Medicine, 6 Diogenous street, 2404 Nicosia, Cyprus
(*) Corresponding Author

Abstract


Background: This manuscript compared the effects at uterine pathology (UP), after processing with either the drug erythropoietin hormone (Epo), or the lazaroid antioxidant agent (L) one U-74389G. This comparison was provided by outcomes of 2 preceding branches.

Objective: Both studies estimated the effect, after each drug use in a planned uterine ischemia -  reperfusion (UIR) mice experimental setting.

Methods: Both principal experiment timepoints, the uterine histology was evaluated were the min 60th after reperfusion (A, C, E groups) and also the min 120th after reperfusion (B, D, F groups). Along, A & B groups were placebo, C & D groups were processed by Epo and E & F groups after the L process.

Results: The one study-branch of Epo has presented a hardly significant recessing potency for the total UP within the “lesion-free” grade alteration by -0.0916667 [-0.1907629 - 0.0074296] (p-values = 0.0583). However, the other study-branch of U-74389G presented a respective non-significant accentuation of the total UP within the “lesion-free” grade alteration by 0.2229748 [-0.1376592 - 0.5836089] (p-value = 0.4940). Both branch studies got co-evaluated as they belong to a common experiment. Their outcome was that Epo seems to ameliorate the UP status, whereas L seems to deteriorate it; however, their discrepancy seems to be non-significant (p-value = 0.0677).

Conclusion: There is a slight non-significant superiority of Epo than L in UIR pathology restoration (p-value = 0.0677), possibly useful in several clinical situations.

 


Keywords


reperfusion; uterus; U-74389G; erythropoietin; ischemia

References


Τsompos C, Panoulis C, Τoutouzas K, Triantafyllou A, Zografos CG, et al. (2019) The Rat Uterus after Erythropoietin Process. Adv Reprod Sci Reprod Health Infertil 2019; 1: 105. DOI: 10.29011/ARRHI-105.100005.

Τsompos C, Panoulis C, Τοutouzas K, Triantafyllou A, Zografos CG, et al. The rat uterus after U-74389G process. Edel J Biomed Res Rev 2019; 1: 1-5.

Dhiman NK, Saini R. Natural antioxidants and their impact on female reproductive health. J Reprod Healthc Med. 2025; 6:5. doi: 10.25259/JRHM_31_2024

Vašková J, Klepcová Z, Špaková I, Urdzík P, Štofilová J, Bertková I, et al. The Importance of Natural Antioxidants in Female Reproduction. Antioxidants (Basel). 2023; 11;12(4): 907. doi: 10.3390/antiox12040907. PMID: 37107282; PMCID: PMC10135990.

Hussain T, Murtaza G, Metwally E, Kalhoro DH, Kalhoro MS, Rahu BA, et al. The Role of Oxidative Stress and Antioxidant Balance in Pregnancy. Mediators Inflamm. 2021; 27: 9962860. doi: 10.1155/2021/9962860. PMID: 34616234; PMCID: PMC8490076.

Ashqar AA, Lulseged B, Mason-Otey A, Liang J, Begum UAM, Afrin S, et al. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications. Antioxidants (Basel). 2023; 26;12(4): 807. doi: 10.3390/antiox12040807. PMID: 37107181; PMCID: PMC10135366.

Kiremitli T, Kiremitli S, Akselim B, Yilmaz B, Mammadov R, Tor IH, et al. Protective effect of Coenzyme Q10 on oxidative ovarian and uterine damage induced by methotrexate in rats. Hum Exp Toxicol. 2021; 40(9): 1537-1544. doi: 10.1177/09603271211002891. Epub 2021 Mar 22. PMID: 33745333.

Agarwal A, Said TM. Oxidative stress, DNA damage and apoptosis in male infertility: a clinical approach. BJU Int. 2005; 95(4): 503-7. doi: 10.1111/j.1464-410X.2005.05328.x. PMID: 15705068.

Lobo RA. Menopause and osteoporosis. Obstetrics & Gynecology Clinics 2005; 32(1): 31-44. https://doi.org/10.1016/j.ogc.2004.10.008

Sen CK. Antioxidant and redox regulation of cellular signaling: introduction. Med Sci Sports Exerc. 2001; 33(3): 368-70. doi: 10.1097/00005768-200103000-00005. PMID: 11252060.

Guo SW. Clinical management of endometriosis. Reproductive Biomedicine Online 2009; 19(2): 254-266. https://doi.org/10.1016/S1472-6483(10)60194-9

Jakubauskiene L, Jakubauskas M, Razanskiene G, Leber B, Weber J, Rohrhofer L, et al. Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia-Reperfusion Injury. Int J Mol Sci. 2022; 27;23(13): 7120. doi: 10.3390/ijms23137120.

Kitase Y, Madurai NK, Hamimi S, Hellinger RL, Odukoya OA, Ramachandra S, et al. Chorioamnionitis disrupts erythropoietin and melatonin homeostasis through the placental-fetal-brain axis during critical developmental periods. Front Physiol 2023; 20:14: 1201699. doi: 10.3389/fphys.2023.1201699

Jakubauskiene L, Jakubauskas M, Razanskiene G, Leber B, Ramasauskaite D, Strupas K, et al. Experimental Static Cold Storage of the Rat Uterus: Protective Effects of Relaxin- or Erythropoietin-Supplemented HTK-N Solutions. Biomedicines 2022; 28;10(11): 2730. doi: 10.3390/biomedicines10112730.

Ii H, Nohara Y, Yoshiya T, Masuda S, Tsuda S, Oishi S, et al. Identification of U83836E as a γ-glutamylcyclotransferase inhibitor that suppresses MCF7 breast cancer xenograft growth. BiochemBiophys Res Commun 2021; 16:549: 128-134. doi: 10.1016/j.bbrc.2021.02.103.

Hill RL, Singh IN, Brelsfoard J, Hall ED. Pharmacological inhibition of lipid peroxidative damage by the 21-aminosteroid U-74389G improves cortical mitochondrial function following traumatic brain injury in young adult male rats. Neuropharmacology 2020; 15:170: 108023. doi: 10.1016/j.neuropharm.2020.108023.

Atallah M, Yamashita T, Hu X, Hu X, Abe K. Edaravone Confers Neuroprotective, Anti-inflammatory, and Antioxidant Effects on the Fetal Brain of a Placental-ischemia Mouse Model. J Neuroimmune Pharmacol 2023; 18(4): 640-656. doi: 10.1007/s11481-023-10095-6. Epub 2023 Nov 4.

Kölükçü V, Balta MG, Tapar H, Karaman T, Karaman S, Unsal V, et al. Dexmedetomidine protects the uterus against ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci 2024; 28(6): 2501-2508. doi:10.26355/eurrev_202403_35757.

Tsompos C, Panoulis C, Triantafyllou A, Zografos C, Zografos CG, Papalois A. Comparative Hypertestosteronemia of Erythropoietin vs U-74389G. Free Radicals and Antioxidants 2024; 14(1): 27-31.

Tsompos C, Panoulis C, Triantafyllou A, Pantos K, Sfakianoudis K, Zografos K, et al. Comparison of the hypoprogesteronaemic effects of erythropoietin and U-74389G in an experimental model of ischaemia–reperfusion in rats. Acta Stud. Med. Biomed 2025; 1(1): 13–17. https://doi.org/10.5281/zenodo.15739081


Article Metrics

Abstract view : 28 times


DOI: https://doi.org/10.26714/magnamed.13.1.2026.%25p

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Indexed by

 

      

 

Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.